GlassScriptPhysician profile
Michael L Ramsey
NPI 1447290044
$35,875.66
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $3,887 · 2021: $5,421 · 2022: $2,411 · 2023: $4,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,057.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $33,742.62 | 2019-2023 | Zodiac |
| Genesys Orthopedics Systems, L.L.C. | $1,037.85 | 2019 | |
| Globus Medical, INC. | $606.78 | 2021 | |
| Osseus Fusion Systems, LLC | $313.64 | 2019 | |
| 7d Surgical INC. | $69.97 | 2019-2020 | |
| Intrinsic Therapeutics | $31.79 | 2021 | |
| Radius Health, INC. | $18.37 | 2021 | |
| Djo, LLC | $15.03 | 2019 | |
| Misonix INC | $13.43 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.40 | 2019 | |
| Horizon Therapeutics Plc | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ramsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.